Skip to main content
OpenTrials
Completed

NCT Number: NCT04343924

Clinical Study About the Effects of Scuba Diving on Post Traumatic Stress Disorder (PTSD)

Post-traumatic stress disorder (PTSD) is a set of symptoms that can be developed as a result of exposure to a traumatic event or events that can range in prevalence from 25% to 75%. While therapeutic management combines psychotherapy, drug therapy and social support, some PTSD remain resistant after early and appropriate initial treatment. In terms of physiopathology, several studies have shown that parasympathetic activity is significantly decreased in patients with PTSD. In scuba diving, the cardio-vascular stresses associated with submersion of the subject and the lungs due to breathing in a regulator are at the origin of a reflex activation of the parasympathetic nervous system. The objective is to study the effects of the scuba diving activities-induced autonomic parasympathetic nervous system activation on the symptomatic progression of patients with PTSD.

The study population will consist of patients monitored and treated for PTSD following the attacks of 14/07/2016 in Nice (France).

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHU de Nice

Nice, 06000, France

About this study

A group will be composed of patients (n=12) who will complete a Scuba Diving Discovery Course (GP+ Diving Group). This course, lasting 2 weeks, will consist of a daily dive, 5 days per week, for a total of 10 dives. These will be supervised by a graduate instructor according to the rules of supervision defined by the sport code. The dives will be conducted in open air, at a maximum depth of 6 meters for a maximum duration of 20 minutes.

A matched group (gender, age, height, weight and BMI) will be composed of patients (n=12) who will not complete the Scuba Diving Discovery Course (GP- Virtual reality group). The subjects of this group will follow virtual reality sessions recreating the environment in which the scuba divers of the GP+ group operate. A control group (GT) will be composed of patients (n=12) who are monitored and treated for PTSD and who will not attend the dive discovery course or virtual reality sessions.

  • The main evaluation criterion will be the NON-INVASIVE determination of salivary alpha amylase.
  • Secondary evaluation criteria will be heart rate variation, CGI, HAD and BECK Anxiety, EGF, PCL-S and IES questionary.

The main objective is to study the effects of immersion and pressure relief ventilation on the activation of the autonomic parasympathetic nervous system.

Secondary objectives are to assess the symptomatic impact of parasympathetic autonomic nervous system activation on overall improvement, anxiety and depressive symptoms, functioning, and the 3 subtypes of PTSD symptoms as vegetative neuro hyperactivity, invasive syndrome and avoiding

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Adult patients
  • Patients who understand and read French
  • Patients who have signed the informed consent form
  • Patients who have never practiced scuba diving
  • Patients medically fit for scuba diving
  • Patients with the DSM-5 criteria for Post-traumatic Stress Disorder
  • PCL-S score strictly greater than 44
  • CGI greater than or equal to 4
  • Chronicity (duration greater than 3 months)

Exclusion criteria

  • Women of reproductive age without contraception
  • Pregnant or nursing women
  • Patients under guardianship or curatorship and detainees of justice
  • Patients who previously practised scuba diving or hold a diving certificate
  • Patients whose medical condition medically contraindicated the practice of scuba diving,
  • Patients having a water phobia, bipolar or psychotic disorder
  • Patients with a severe and proven suicidal risk (MINI-S and medical examination)
  • Patients treated for less than 2 months with antidepressants;
  • Patients treated for less than 2 months with specific psychotherapy (Cognitive and Behavioural Therapy, EMDR)
  • Patients with response to treatment (50% decrease in symptoms)
  • Contraindications to the practice of virtual reality.

Treatment and study plan

Scuba diving activities

Other

The subjects of this group daily dive, 5 days per week, for a total of 10 dives at a maximum depth of 6 meters for a maximum duration of 20 minutes in a swimming pool.

Virtual reality activities

Other

The subjects of this group will follow virtual reality sessions recreating the environment in which the submarine diver of the GP+ group operates

Primary outcomes

  1. The main objective is to study the physiological effects of pressure regulator immersion

    Time frame: 6 months

    Measure of parterial pressure

  2. The main objective is to study the physiological effects of regulator ventilation on the activation of the parasympathetic autonomic nervous system

    Time frame: 6 months

    Measure of O2 saturation

Sponsors and collaborators

Lead sponsor

Centre Hospitalier Universitaire de Nice

Other

Registry information

Official study title

Clinical Study: Physiological Effects of Scuba Diving on PTSD by Activating the Parasympathetic System and Restoring the Optimal and Sustainable State of Balance Between the Sympathetic and Parasympathetic Autonomous Nervous System (Sympatho-vagale Scale)

Acronym: DIVE4NICE

Important dates

Study start
2023
Primary completion
2023
Study completion
2023
First posted
Apr 14, 2020
Registry last updated
Jan 12, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.